HTAccess Consulting can provide end-to-end support to your organisation through its interaction with the Pharmaceutical Benefits Advisory Committee (PBAC). In doing so HTAccess Consulting brings experience obtained from the preparation of successful PBAC submissions in the areas of: oncology; HIV; Hepatitis C; respiratory disease; diabetes; and biosimilar medicines.

 

HTAccess Consulting also has experience with Managed Entry Scheme (Managed Access Program) and co-dependent technology PBAC submissions and can provide expert support to your organisation to gain PBS listing via these mechanisms.

 

Whether seeking reimbursement for a first-in-class; biosimilar; or a co-dependent technology product, HTAccess Consulting provides the support you need to achieve timely patient access to your organisations product.